Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose tegoprazan + amoxicillin dual therapy vs bismuth metronidazole quadruple therapy for Helicobacter pylori eradication
ChiCTR2400081873Phase 4Recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoint: Comparison of Helicobacter pylori eradication rate. Started Jan 2024; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400081873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081873.